Merck

Moderna, Merck Cancer Vaccine-Keytruda Combo Gets Win at Three-Year Mark
BioSpace
Thu, 12/14/23 - 10:55 pm
Moderna Therapeutics
Merck
vaccines
Keytruda
melanoma
MRNA
Merck offers up to $610M for one of C4’s protein degraders
Fierce Biotech
Tue, 12/12/23 - 11:07 am
Merck
C4 Therapeutics
protein degradation
Moderna, Merck begin late-stage study for mRNA cancer therapy
Reuters
Mon, 12/11/23 - 10:00 am
Moderna Therapeutics
Merck
MRNA
cancer
clinical trials
Merck suffers bad week as 3 Keytruda combination trials fail
BioPharma Dive
Sun, 12/10/23 - 11:19 pm
Merck
Keytruda
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer
Fierce Pharma
Thu, 12/7/23 - 12:00 pm
Merck
Keytruda
non-small cell lung cancer
Lynparza
AstraZeneca
Merck partners with HiberCell for Phase Ib renal carcinoma trial
Clinical Trials Arena
Wed, 12/6/23 - 10:29 am
Merck
HiberCell
Welireg
HC-7366
renal cell carcinoma
BMS chases Merck/Seagen with first-line bladder cancer filing
Pharmaphorum
Tue, 12/5/23 - 11:53 pm
Bristol Myers Squibb
Opdivo
bladder cancer
urothelial cancer
Merck
Seagen
FDA starts review of Padcev/Keytruda for bladder cancer
Pharmaphorum
Fri, 12/1/23 - 09:35 am
Merck
Astellas
Seagen
Padcev
bladder cancer
FDA
priority review
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Merck
GSK
chronic cough
Bellus Health
gefapixant
Camlipixant
Merck turns to Acclinate to increase African American participation in cancer trials
Fierce Biotech
Thu, 11/30/23 - 09:52 am
Merck
clinical trials
clinical trial diversity
Acclinate
cancer
digital health
Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators
Fierce Pharma
Tue, 11/28/23 - 11:52 am
Merck
Pfizer
vaccines
clinical trials
pneumococcal disease
V116
Prevnar 20
Merck Drops Up to $610M on Neuro Disease-Focused Caraway Therapeutics
BioSpace
Tue, 11/21/23 - 12:05 pm
Merck
M&A
neurodegenerative disease
Caraway Therapeutics
5 Cancer Vaccines to Watch in 2024
BioSpace
Mon, 11/20/23 - 10:15 am
Merck
Moderna Therapeutics
melanoma
BioNTech
pancreatic cancer
OSE Immunotherapeutics
Transgene
non-small cell lung cancer
Nykode Therapeutics
cervical cancer
FDA panel flags insufficient data for Merck's chronic cough drug
Reuters
Sun, 11/19/23 - 09:32 pm
Merck
FDA
chronic cough
gefapixant
Merck Expands Keytruda’s Label as a First-Line Option for Gastric Cancer
BioSpace
Fri, 11/17/23 - 11:48 am
Merck
Keytruda
gastric cancer
FDA skeptical of Merck’s gefapixant, even after cough recount
Fierce Biotech
Thu, 11/16/23 - 11:34 am
Merck
chronic cough
gefapixant
Merck-backed VectorY Therapeutics raises $138M series A to push forward ALS program
Fierce Biotech
Tue, 11/14/23 - 09:28 am
VectorY Therapeutics
funding
ALS
Merck
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
Motley Fool
Sun, 11/12/23 - 09:30 pm
Merck
Bristol Myers Squibb
antibody-drug conjugate
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Wed, 11/1/23 - 10:10 pm
Merck
AstraZeneca
biliary tract cancer
Keytruda
Imfinzi

Pages